# OnCo record accsalus-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/accsalus-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "accsalus-biosciences" ;
  schema:name "AccSalus Biosciences"@en ;
  schema:alternateName "AccSalus Scitech Inc."@en, "AccSalus"@en ;
  schema:description "AccSalus uses computer models to design new drug molecules; its first cancer medicine, a tablet that blocks several growth-signalling proteins, is about to enter a first trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/accsalus-biosciences/>, <https://accsalus.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://accsalus.com/>, <https://clinicaltrials.gov/study/NCT07252661> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/rcc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/ai-computation/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/ai-drug-design/> .
